2026-526299-21-00招募中1 期
An Open-Label Study of IDE034 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
IDEAYA clinical trials
Scientific
Ideaya Biosciences Inc.
研究点 (3)
Loading locations...
相似试验
招募中
不适用
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes (J2A-MC-GZGY)Diabetes Mellitus, Type 2jRCT2031260316170
尚未招募
不适用
A Randomized, Open-Label, Controlled Phase 3 Study Comparing Daratumumab, Lenalidomide and Dexamethasone Induction followed by Linvoseltamab Versus continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma PatientsNewly Diagnosed Transplant Ineligible Multiple MyelomajRCT207125011860
尚未招募
不适用
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) (KRASCENDO 3)KRAS G12C-positive Stage II-IIIB NSCLCjRCT2051260138400
招募中
不适用
CaDance304B-cell malignanciesjRCT2031250598500
招募中
1 期
A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.Hepatic InsufficiencyNCT07401862Eli Lilly and Company36